Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Caribou Biosciences (CRBU) Preferred Shares Issued (2021)

Caribou Biosciences has reported Preferred Shares Issued over the past 1 years, most recently at -$408000.0 for Q2 2021.

Quarterly Preferred Shares Issued changed N/A to -$408000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was -$408000.0 through Mar 2022, changed N/A year-over-year, with the annual reading at $108.8 million for FY2021, N/A changed from the prior year.
Preferred Shares Issued was -$408000.0 for Q2 2021 at Caribou Biosciences, down from $109.2 million in the prior quarter.
Over five years, Preferred Shares Issued peaked at $109.2 million in Q1 2021 and troughed at -$408000.0 in Q2 2021.